CA2971517C - Anticorps anti-il-34 - Google Patents

Anticorps anti-il-34

Info

Publication number
CA2971517C
CA2971517C CA2971517A CA2971517A CA2971517C CA 2971517 C CA2971517 C CA 2971517C CA 2971517 A CA2971517 A CA 2971517A CA 2971517 A CA2971517 A CA 2971517A CA 2971517 C CA2971517 C CA 2971517C
Authority
CA
Canada
Prior art keywords
antibody
antigen
antibodies
binding
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2971517A
Other languages
English (en)
Other versions
CA2971517A1 (fr
Inventor
Dominique Heymann
Aude Segaliny
Regis Brion
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Universite de Nantes
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Nantes, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Universite de Nantes
Priority claimed from PCT/EP2015/080866 external-priority patent/WO2016097420A1/fr
Publication of CA2971517A1 publication Critical patent/CA2971517A1/fr
Application granted granted Critical
Publication of CA2971517C publication Critical patent/CA2971517C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne de nouveaux anticorps anti-IL-34 ou leurs fragments de liaison à l'antigène se liant spécifiquement à la cytokine IL-34 avec une affinité élevée, le procédé d'obtention de ces anticorps et leur utilisation thérapeutique.
CA2971517A 2014-12-19 2015-12-21 Anticorps anti-il-34 Active CA2971517C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14199494.7 2014-12-19
EP14199494 2014-12-19
PCT/EP2015/080866 WO2016097420A1 (fr) 2014-12-19 2015-12-21 Anticorps anti-il-34

Publications (2)

Publication Number Publication Date
CA2971517A1 CA2971517A1 (fr) 2016-06-23
CA2971517C true CA2971517C (fr) 2026-05-12

Family

ID=

Similar Documents

Publication Publication Date Title
EP3233897B1 (fr) Anticorps anti il-34
TWI770020B (zh) 人類化抗pacap 抗體及其用途
ES2639056T3 (es) Anticuerpos anti-EGFR y sus usos
JP2015501639A (ja) 抗ｃｄ９８抗体およびその使用方法
JP6931648B2 (ja) 抗ｉｌ−１７ａ／ｆ抗体を用いた治療方法
EP4101867A1 (fr) Anticorps bispécifique anti-cd3 et anti-cd123 et son utilisation
KR20220152262A (ko) 항-인터루킨-33 항체 및 이의 용도
TW201333034A (zh) 新穎抗人類ｃｔｇｆ抗體
CN112041346B (zh) 用于与抗pd-1抗体组合的抗cd137抗体
JP7430137B2 (ja) 抗体および使用方法
JP2019534850A (ja) 抗ｇｍ−ｃｓｆ抗体およびその使用
KR20240099146A (ko) 항-acvr2a 항체 및 이의 용도
JP7673981B2 (ja) 抗ｃｘｃｒ２抗体およびその使用
CN112020517B (zh) 用于与抗pd-l1抗体组合的抗cd137抗体
CN118317788B (zh) Tnfr2结合分子及其用途
WO2019113306A2 (fr) Anticorps anti-rspo3
EP4070816A1 (fr) Anticorps anti-gdf15
JP2026500012A (ja) 抗ベータカテニン抗体
HK40075921A (en) Anti-gdf15 antibody
HK40081009A (en) Anti-gdf15 antibody
CN116897164A (zh) 抗vegf抗体及其用途
HK40019208B (en) Anti-cd137 antibodies
JP2019507744A (ja) テネイシンに対するヒト抗体及びその結合断片